Risk-based classification of leukemia by cytogenetic and multiplex molecular methods: Results from a multicenter validation study

Blood Cancer Journal

Volumn 2, Issue 7, 2012, Pages

  Gocke, C D ^a   Mason, J ^b   Brusca, L ^c   Laosinchai Wolf, W ^d   Higgs, C ^a   Newell, H ^b   Masters, A ^c   Friar, L ^d   Karp, J ^a   Griffiths, M ^b   Wei, Q ^c   Labourier, E ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c CHILDREN S HOSPITAL COLORADO   (United States)

^d ASURAGEN INC   (United States)

Author keywords

Diagnosis; Leukemia; Molecular classification; Multiplex; Prognosis; RT PCR

Indexed keywords

BCR ABL PROTEIN; RNA; TRANSCRIPTION FACTOR 7 LIKE 1; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR PBX1; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALTERNATIVE RNA SPLICING; ARTICLE; CANCER PROGNOSIS; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; LEUKEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84865999809     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2012.24     Document Type: Article

References (32)

1. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood, 2009; 114: 937-951.
2. Harrison CJ, Haas O, Harbott J, Biondi A, Stanulla M, Trka J et al. Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfurt-Munster study group. Br J Haematol 2010; 151: 132-142.
3. Harrison CJ, Secker-Walker LM. The importance of cytogenetics and associated molecular techniques in the management of patients with leukaemia. Clin Oncol 1998; 10: 255-261.
4. Salto-Tellez M, Shelat SG, Benoit B, Rennert H, Carroll M, Leonard DG et al. Multiplex RT-PCR for the detection of leukemia-associated translocations: validation and application to routine molecular diagnostic practice. J Mol Diagn 2003; 5: 231-236.
5. Pallisgaard N, Hokland P, Riishoj DC, Pedersen B, Jorgensen P. Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 trans-locations and chromosomal aberrations in acute leukemia. Blood 1998; 92: 574-588.
6. Rowe D, Cotterill SJ, Ross FM, Bunyan DJ, Vickers SJ, Bryon J et al. Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia. Br J Haematol 2000; 111: 1051-1056.
7. van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901-1928.
8. Andersson A, Hoglund M, Johansson B, Lassen C, Billstrom R, Garwicz S et al. Paired multiplex reverse-transcriptase polymerase chain reaction (PMRT-PCR) analysis as a rapid and accurate diagnostic tool for the detection of MLL fusion genes in hematologic malignancies. Leukemia 2001; 15: 1293-1300.
9. Elia L, Mancini M, Moleti L, Meloni G, Buffolino S, Krampera M et al. A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. Haematologica 2003; 88: 275-279.
10. Jansen MW, van der Velden VH, van Dongen JJ. Efficient and easy detection of MLL-AF4, MLL-AF9 and MLL-ENL fusion gene transcripts by multiplex realtime quantitative RT-PCR in TaqMan and LightCycler. Leukemia 2005; 19: 2016-2018.
11. King RL, Naghashpour M, Watt CD, Morrissette JJ, Bagg A. A comparative analysis of molecular genetic and conventional cytogenetic detection of diagnostically important translocations in more than 400 cases of acute leukemia, highlighting the frequency of false-negative conventional cytogenetics. Am J Clin Pathol 2011; 135: 921-928.
12. Nasedkina T, Domer P, Zharinov V, Hoberg J, Lysov Y, Mirzabekov A. Identification of chromosomal translocations in leukemias by hybridization with oligonucleo-tide microarrays. Haematologica 2002; 87: 363-372.
13. Olesen LH, Clausen N, Dimitrijevic A, Kerndrup G, Kjeldsen E, Hokland P. Prospective application of a multiplex reverse transcription-polymerase chain reaction assay for the detection of balanced translocations in leukaemia: a single-laboratory study of 390 paediatric and adult patients. Br J Haematol 2004; 127: 59-66.
14. Pakakasama S, Kajanachumpol S, Kanjanapongkul S, Sirachainan N, Meekaewkunchorn A, Ningsanond V et al. Simple multiplex RT-PCR for identifying common fusion transcripts in childhood acute leukemia. Int J Lab Hematol 2008; 30: 286-291.
15. Wallace J, Zhou Y, Usmani GN, Reardon M, Newburger P, Woda B et al. BARCODE-ALL: accelerated and cost-effective genetic risk stratification in acute leukemia using spectrally addressable liquid bead microarrays. Leukemia 2003; 17: 1404-1410.
16. Hafez M, Ye F, Jackson K, Yang Z, Karp JE, Labourier E et al. Performance and clinical evaluation of a sensitive multiplex assay for the rapid detection of common NPM1 mutations. J Mol Diagn 2010; 12: 629-635.
17. Ye F, Laosinchai-Wolf W, Labourier E. An optimized technology platform for the rapid multiplex molecular analysis of genetic alterations associated with leukemia. Cancer Genetics (in press).
18. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 2003; 17: 2318-2357.
19. Biondi A, Rambaldi A, Rossi V, Elia L, Caslini C, Basso G et al. Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation. Blood 1993; 82: 2943-2947.
20. Claxton DF, Liu P, Hsu HB, Marlton P, Hester J, Collins F et al. Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood 1994; 83: 1750-1756.
21. Huang W, Sun GL, Li XS, Cao Q, Lu Y, Jang GS et al. Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse. Blood 1993; 82: 1264-1269.
22. Hunger SP, Galili N, Carroll AJ, Crist WM, Link MP, Cleary ML. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lym-phoblastic leukemias. Blood 1991; 77: 687-693.
23. Nucifora G, Birn DJ, Erickson P, Gao J, LeBeau MM, Drabkin HA et al. Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood 1993; 81: 883-888.
24. Rubnitz JE, Downing JR, Pui CH, Shurtleff SA, Raimondi SC, Evans WE et al. TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. J Clin Oncol 1997; 15: 1150-1157.
25. Hermans A, Selleri L, Gow J, Wiedemann LM, Grosveld G. Molecular analysis of the Philadelphia translocation in chronic myelogenous and acute lymphoblastic leukemia. Cancer Cells 1989; 7: 21-26.
26. Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 2008; 29(Suppl 1): S49-S52.
27. Verma D, Kantarjian HM, Jones D, Luthra R, Borthakur G, Verstovsek S et al. Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance. Blood 2009; 114: 2232-2235.
28. Schlenk RF, Dohner K, Krauter J, Frohling S, Corbacioglu A, Bullinger L et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358: 1909-1918.
29. Privitera E, Luciano A, Ronchetti D, Arico M, Santostasi T, Basso G et al. Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL). Leukemia 1994; 8: 554-559.
30. Satake N, Kobayashi H, Tsunematsu Y, Kawasaki H, Horikoshi Y, Koizumi S et al. Minimal residual disease with TEL-AML1 fusion transcript in childhood acute lymphoblastic leukaemia with t(12;21). Br J Haematol 1997; 97: 607-611.
31. Lo Coco F, Diverio D, Falini B, Biondi A, Nervi C, Pelicci PG. Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia. Blood 1999; 94: 12-22.
32. van der Reijden BA, Lombardo M, Dauwerse HG, Giles RH, Muhlematter D, Bellomo MJ et al. RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts. Blood 1995; 86: 277-282.